Vector-borne diseases account for a significant fraction of the global infectious disease burden, contributing to more than 700,000 deaths annually. Of the known vectors, hematophagous arthropods, such as mosquitoes, ticks, and sand flies, are responsible for the transmission of some of the most devastating diseases throughout the world.

Presently, vaccines are not available for many vector-borne diseases and treatment may be limited. Further, accurate diagnosis of these diseases can be complicated due to a variety of factors, including analogous clinical presentation, serological cross-reactivity, or the possibility of co-infection. Thus, accurate methods for early detection are imperative in managing microbial dissemination and minimizing the impact of these diseases on public health.

To aid in these efforts, ATCC offers a wide range of microorganisms and nucleic acids that support research on prevalent vector-borne diseases such as Zika, dengue, chikungunya, malaria, Lyme disease, and babesiosis. Our high-quality, authenticated reference materials are ideal for use in the development and evaluation of novel vaccines, innovative therapeutics, and rapid diagnostic tools.